Expert panel likely to meet on Jan 1 to take final call on approval of vaccines, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The drug regulator’s Subject Expert Committee (SEC) on Covid-19 vaccine sought more time to analyse the updated data submitted by both Serum Institute of India and Bharat Biotech seeking emergency use authorization (EUA) for their respective vaccine candidates against SARS-CoV2., The drug regulator’s Subject Expert Committee (SEC) on Covid-19 vaccine sought more time to analyse the updated data submitted by both Serum Institute of India and Bharat Biotech seeking emergency use authorization (EUA) for their respective vaccine candidates against SARS-CoV2., , Read More